SEFIRA Trademark

Trademark Overview


On Wednesday, November 24, 2021, a trademark application was filed for SEFIRA with the United States Patent and Trademark Office. The USPTO has given the SEFIRA trademark a serial number of 79335517. The federal status of this trademark filing is REGISTERED as of Tuesday, October 31, 2023. This trademark is owned by Sutara SA. The SEFIRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, antibiotics; diagnostic preparations for medical and veterinary use; sanitary preparations for medical purposes; dietetic food and preparations adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; plasters, namely, materials for medical dressings; disinfectants; adjuvants for medical purposes; cooling sprays for medical purposes; albumin dietary supplements; alginate dietary supplements; amino acids for medical purposes; amino acid preparations for medical purposes; analgesics; anaesthetics; vermifuges; anti-uric preparations; antibacterial pharmaceuticals; antiseptics; autonomic drugs for medical purposes in treating diseases or disorders related to the parasympathetic nervous system; germicides; balms for medical purposes; balsamic preparations for medical purposes; albuminous preparations being dietetic foods for medical purposes; albuminous foodstuffs for medical purposes; activated charcoal dietary suppl...
sefira

General Information


Serial Number79335517
Word MarkSEFIRA
Filing DateWednesday, November 24, 2021
Status700 - REGISTERED
Status DateTuesday, October 31, 2023
Registration Number7203830
Registration DateTuesday, October 31, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 15, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized wording SEFIRA and a design comprising two intersecting oblongs.
Goods and ServicesPharmaceuticals, namely, antibiotics; diagnostic preparations for medical and veterinary use; sanitary preparations for medical purposes; dietetic food and preparations adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; plasters, namely, materials for medical dressings; disinfectants; adjuvants for medical purposes; cooling sprays for medical purposes; albumin dietary supplements; alginate dietary supplements; amino acids for medical purposes; amino acid preparations for medical purposes; analgesics; anaesthetics; vermifuges; anti-uric preparations; antibacterial pharmaceuticals; antiseptics; autonomic drugs for medical purposes in treating diseases or disorders related to the parasympathetic nervous system; germicides; balms for medical purposes; balsamic preparations for medical purposes; albuminous preparations being dietetic foods for medical purposes; albuminous foodstuffs for medical purposes; activated charcoal dietary supplements; biological preparations for medical purposes for the treatment of cancer; bronchodilating preparations; vaccines; vitamin preparations; vitamin and mineral preparations for medical use; lead water, namely, dietetic beverages for treating heavy metal poisoning; mineral waters for medical purposes; dietary fibre for use as a dietary supplement; herbal remedies, namely, herbal extracts for medical purposes; homogenized food adapted for medical purposes; disinfectants for hygiene purposes; diagnostic preparations for medical purposes; dietary supplements; nutritional and dietary supplements for stress relief; antioxidants being dietary supplements; anti-cancer preparations; nutritional and dietary supplements for strengthening the immune system; dietary supplements intended to supplement a normal diet or to have health benefits; dietary supplements consisting of vitamins; royal jelly dietary supplements; glucose dietary supplements; pollen dietary supplements; dietary supplements with a cosmetic effect; linseed dietary supplements; linseed oil dietary supplements; acai powder dietary supplements; propolis dietary supplements; wheat germ dietary supplements; natural dietary supplements for treatment of claustrophobia; dietetic beverages adapted for medical purposes; dietetic preparations adapted for medical use; dietetic foods adapted for medical purposes; yeast dietary supplements; plant extracts for pharmaceutical purposes; herbal extracts for medical purposes; elixirs being pharmaceutical preparations for treatment of headache; enzyme dietary supplements; febrifuges; carbohydrate-based dietary supplements; blood substitutes for medical or veterinary purposes; nervines being medicines for treatment of nerve disorders; drugs for medical purposes in the treatment of nervous system disorders; recombinant drug-metabolizing enzyme being biochemical preparations for veterinary purposes; immunostimulants; casein dietary supplements; amino acids for pharmaceutical purposes; medicinal roots; depuratives for the body; lecithin dietary supplements; medicines for human purposes in the treatment of nervous system disorders; medicated candy; lotions for pharmaceutical purposes in the treatment of dermatological conditions; magnesia for pharmaceutical purposes as an antacid and dietary supplement; medicated soap; mineral food supplements; vitamins; vitamin supplement patches; medicinal drinks; medicinal infusions for treating gastrointestinal disorders; herbal tinctures for medical purposes; nutraceutical preparations for therapeutic or medical purposes as a dietary supplement; fumigating sticks; fumigation preparations for medical purposes; medicinal oils; mouthwashes for medical purposes; headache relief sticks; antioxidant food supplement pills; by-products of the processing of cereals for medical purposes including as dietetic preparations adapted for medical use; nutritional supplements; preparations in the nature of sexual stimulants for increasing sexual prowess; human immune globulin for use in autoimmune medical treatments; therapeutic drugs and agents for weight control and appetite suppression; pre-filled syringes for medical purposes sold filled with insulin; bath preparations for medical purposes; dietary supplements for animals; pharmaceutical preparations for the treatment and prevention of influenza; opotherapy preparations; preparations of trace elements in the nature of dietary and nutritional supplements for human and animal use; medicated toiletry preparations; freezedried food adapted for medical purposes; protein dietary supplements; soy protein dietary supplements; antivirals; antiarrhythmic drugs; anti-inflammatories; antiepileptic drugs; antitumor drugs; sedatives; tissues impregnated with pharmaceutical skin lotions; syrups for pharmaceutical purposes for treatment of cough and cold; medicated salts for mineral water baths; mineral water salts for medical purposes; vegan protein for use as a nutritional supplement in ready-to-drink beverages; cough pastilles for pharmaceutical purposes; therapeutic preparations for the bath; thermal water, namely, vitamin and mineral enriched water for medical purposes; tonics, namely, medicines for use in the treatment of cardiovascular diseases; medicinal herbs; pharmaceuticals, namely, antihelmintics, psychotropics; pharmaceutical substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, and cognitive disorders; ferments for pharmaceutical purposes; diarrhoea medication; phytotherapy preparations for medical purposes; dietary food supplements for medical purposes; medicated sweets; medicinal tea; asthmatic tea; herbal teas for medicinal purposes; medicated shampoos; medicated dry shampoo

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSutara SA
Party Type30 - Original Registrant
Legal Entity Type85 - NOT AVAILABLE
AddressCH

Party NameSutara SA
Party Type20 - Owner at Publication
Legal Entity Type85 - NOT AVAILABLE
AddressCH

Party NameSutara SA
Party Type10 - Original Applicant
Legal Entity Type85 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, February 26, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 1, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 1, 2024FINAL DISPOSITION PROCESSED
Wednesday, January 31, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 31, 2023REGISTERED-PRINCIPAL REGISTER
Sunday, September 3, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, August 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, August 15, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2023PUBLISHED FOR OPPOSITION
Monday, August 14, 2023NOTIFICATION PROCESSED BY IB
Wednesday, July 26, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 26, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 13, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, July 13, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 13, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, July 13, 2023EXAMINERS AMENDMENT -WRITTEN
Saturday, June 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 9, 2023REFUSAL PROCESSED BY IB
Friday, December 16, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 16, 2022REFUSAL PROCESSED BY MPU
Tuesday, September 13, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 12, 2022NON-FINAL ACTION WRITTEN
Tuesday, September 6, 2022ASSIGNED TO EXAMINER
Tuesday, March 15, 2022APPLICATION FILING RECEIPT MAILED
Friday, March 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 10, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB